BA
The Boeing Company
BA's fundamentals are strong: its operating margin went from −10% to 10% and revenue grew 18%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
HSHP
Himalaya Shipping Ltd.
There isn't enough reported data to score HSHP yet.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
HSHP Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Strong | |
| Unavailable | |
| Weak |
HSHP's profitability is currently strong, but its balance sheet is weak. There isn't enough data to rate its revenue and cash flow.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA has the edge over HSHP in the historical PE scenario, which offers more potential upside but is not a forecast.
HSHP PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $16.13 | — |
| Cheap | 14x | $16.08 | -0.3% |
| Current | 14x | $16.13 | — |
| Fair | 38x | $43.30 | +168% |
| Expensive | 188x | $212 | +1216% |
Historical ranges are pointers, not guarantees.
HSHP's PE is 14x, but its earnings don't support one, so it isn't a reliable read right now.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
BA has the edge over HSHP on the outlook, with more favorable earnings and revenue expectations.
HSHP Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong decline | |
| Decline | |
| Strongly weakening | |
| Limited | |
| Moderate |
Analysts expect HSHP's earnings and revenue to decline, with profitability weakening.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has returned to profit: it earned $9.66 per share over the past year, after losing money the year before.
HSHP Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.30 | +15% |
| Q2 2026 | $1.13 | +653% |
| Q4 2025 | $0.38 | -21% |
| Q4 2024 | $0.48 | +1100% |
| Q4 2023 | $0.04 | +$0.10 |
HSHP has the edge over BA in the latest year-over-year earnings comparison.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA's revenue has grown year over year for seven quarters in a row: $24.2B last quarter, up 3.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA's operating margin was 1.5% last quarter, up 22 points from the same quarter a year ago.
HSHP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $87.3M | +68% |
| Q4 2025 | $80M | +16% |
| Q2 2025 | $51.9M | -5.3% |
| Q4 2024 | $68.8M | +87% |
HSHP has the edge over BA in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 62% | +8.9 points |
| Q4 2025 | 60% | +20 points |
| Q2 2025 | 39% | N/A |
| Q4 2024 | 55% | N/A |
| Q2 2024 | 53% | N/A |
| Q4 2023 | 40% | N/A |
HSHP has the edge over BA on profitability, with a higher operating margin.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA's free cash flow has turned positive after six years mostly in the red: $16M over the past year.
HSHP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2022 | -$15.5M | +$26.2M |
| Q2 2022 | -$14.9M | -$14.9M |
HSHP and BA do not have enough comparable growth data to identify a winner.
BA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +2.1M shares |
| 1 year | +4.3% | +32.8M shares |
| 3 years | +31% | +186M shares |
| 5 years | +35% | +204M shares |
| Available history | +40% | +227M shares |
BA has the edge over HSHP on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
HSHP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.6% | +1.2M shares |
| 1 year | +7.6% | +3.3M shares |
HSHP has 47M diluted shares, up 7.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q2 2021 | — |
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA has the edge over HSHP on leverage, with a lower net debt burden relative to earnings.
HSHP Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 4.9x | High |
| Q4 2025 | 6.7x | High |
| Q2 2025 | 7.8x | High |
| Q4 2024 | 7.5x | High |
| Q4 2023 | 17.4x | High |
HSHP's net debt is about 4.9 years of its operating earnings (EBITDA), down from 17 years a year ago.
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
HSHP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.4 | Neutral |
| Stochastic | 28.1 | Neutral |
HSHP's weekly RSI is 51 (neutral) and its Stochastic is 28 (neutral).
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA is trading at 18x earnings, a 26% discount to the Industrials sector's median of 24x, though its earnings don't support one.
HSHP PE vs Industrials Sector
| Metric | HSHP | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 24x | 41% below |
| PE % | 18 | 59 | 41 pts below |
HSHP has the edge over BA on valuation relative to its sector.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
HSHP has stronger trend alignment. BA is above 0 of 5 weekly averages versus HSHP above 2 of 4.
HSHP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $16.8 | 4% below |
| 20 week MA | $16.6 | 2.6% below |
| 50 week MA | $14.1 | 15% above |
| 100 week MA | $10.3 | 57% above |
HSHP has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 57% above its 100-week average.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has finished lower in four of the last six years. It's down 21% so far in 2026.
HSHP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $5.80 | $6.76 | +17% |
| 2024 | $6.76 | $4.85 | -28% |
| 2025 | $4.85 | $8.96 | +85% |
| 2026 YTD | $8.96 | $16.1 | +80% |
HSHP has the edge over BA on returns for 2026, with the stronger performance.